Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches:
Financial Report: Sanofi

July 26, 2012
Loss of $205 million to generic competition in the quarter  Read More »
Financial Report: Roche

July 26, 2012
Nutley closure impacts earnings  Read More »
Financial Report: Covance

July 26, 2012
Late-Stage Development revenues up 13%  Read More »
Dalton Helps Duke-NUS Achieve Clinical Milestone

July 26, 2012
Completes API development and manufacture for Phase I trial  Read More »
Bio-Rad, Myriad RBM To Commercialize Biomarker Kits

July 26, 2012
New assays expand Bio-Rad’s current suite  Read More »
Coldstream Upgrades Sterile Manufacturing

July 25, 2012
Expands capacity for parenteral products  Read More »
Financial Report: Bristol-Myers Squibb

July 25, 2012
Patent expirations impact results  Read More »
Financial Report: Lilly

July 25, 2012
Revenues down 10% impacted by Zyprexa patent expiry   Read More »
Financial Report: GlaxoSmithKline

July 25, 2012
Pharmaceutical sales down 3%  Read More »
Financial Report: Alexion

July 25, 2012
Revenues up 48% in the quarter  Read More »
Financial Report: Biogen Idec

July 24, 2012
Revenues up 18% in the quarter  Read More »
Catalent Begins Supply of Abilify ODT

July 24, 2012
Plans further investment in Zydis UK operations  Read More »
PAREXEL Launches BioPharm Unit

July 24, 2012
Will focus on speeding development goals  Read More »
Financial Report: ICON

July 24, 2012
Restructuring charges impact earnings  Read More »
Theorem Names Global Project VP

July 24, 2012
Gordon to oversee activities in more than 10 countries  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: